Authors: SAMS WM

Citation: Wm. Sams, THE CORRODING OF OUR CORE, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 983-986

Authors: PETERMAN A SCHEEL M SAMS WM PANDYA AG

Citation: A. Peterman et al., HEREDITARY ANETODERMA, Journal of the American Academy of Dermatology, 35(6), 1996, pp. 999-1000

Authors: SAMS WM OMURA EF BARTOLUCCI AA COOK WJ OMURA GA

Citation: Wm. Sams et al., DOUBLE-BLIND, PAIRED-COMPARISON OF BCX-34 VERSUS PLACEBO IN THE TREATMENT OF PSORIASIS-VULGARIS, Journal of investigative dermatology, 106(4), 1996, pp. 836-836

Authors: SALEH MN DIASIO RB SAMS WM WHEELER RH GREGG X OMURA GA WALSH GM

Citation: Mn. Saleh et al., PHASE-I EVALUATION OF ORAL BCX-34 (PELDESINE) IN CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 88(10), 1996, pp. 2277-2277

Authors: SAMS WM

Citation: Wm. Sams, HEALTH-CARE SYSTEM REFORM AND THE AMERICAN-ACADEMY-OF-DERMATOLOGY, Archives of dermatology, 132(5), 1996, pp. 586-586

Authors: PEUGEOT RL SAMS WM OMURA EF COOK WJ SNYDER HW

Citation: Rl. Peugeot et al., CLINICAL EFFICACY OF A NOVEL PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR (BCX-34) IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 104(4), 1995, pp. 563-563